In ₹ Crore except Per Share Latest Annual	ARTEMISMED FY26	INDRAMEDCO FY26	SHALBY FY26	GKSL FY26	Peer Average
Valuation — at last close
P/E	45.42×	◆ 15.89×	37.76×	69.02×	40.89× +11%
P/B	5.05×	3.94×	◆ 1.30×	5.37×	3.54× +43%
EV/EBITDA	25.21×	◆ 9.95×	12.38×	48.88×	23.73× +6%
Market Cap	₹4,717 Cr	₹2,918 Cr	₹1,311 Cr	₹1,355 Cr	₹1,861 Cr +153%
Growth
Revenue CAGR 3Y	◆ 13.61%	10.50%	12.35%	—	11.43% +19%
Revenue CAGR 5Y	◆ 21.50%	19.30%	—	—	19.30% +11%
Net Income CAGR 3Y	◆ 39.74%	28.69%	-19.97%	—	4.36% +811%
Revenue YoY (latest Q)	◆ 13.23%	8.35%	11.74%	—	10.04% +32%
Net Income YoY (latest Q)	3.66%	8.33%	◆ 36.70%	—	22.52% -84%
Profitability
EBITDA Margin	17.40%	18.00%	12.51%	◆ 32.85%	21.12% -18%
Net Income Margin	9.59%	12.39%	3.04%	◆ 20.50%	11.98% -20%
Return on Common Equity	11.69%	◆ 27.47%	3.74%	6.14%	12.45% -6%
Return on Capital Employed	11.88%	◆ 29.88%	5.79%	8.24%	14.64% -19%
Return on Assets	7.45%	◆ 19.93%	1.96%	5.65%	9.18% -19%
Credit & Quality
Total Debt/Equity	0.24×	◆ 0.00×	0.54×	0.06×	0.20× +20%
Interest Coverage	5.06×	◆ 37.09×	1.87×	11.84×	16.93× -70%
Scale — latest FY
Revenue / Total Income	₹1,081 Cr	₹1,483 Cr	₹1,141 Cr	₹82 Cr	₹902 Cr +20%
Net Income	₹104 Cr	₹184 Cr	₹34.7 Cr	₹16.8 Cr	₹78.4 Cr +32%
Total Assets	₹1,429 Cr	₹991 Cr	₹1,839 Cr	₹298 Cr	₹1,043 Cr +37%
EPS	₹6.56	₹20.03	₹3.23	₹2.49	₹8.58 -24%
Book Value per Share	₹59.04	₹80.76	₹93.49	₹32.03	₹68.76 -14%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.